PMID: 3757162Jan 1, 1986Paper

Anti-emetic efficacy of dexamethasone in combination for out-patients receiving cytotoxic chemotherapy

Cancer Chemotherapy and Pharmacology
S G AllanR C Leonard

Abstract

A single blind randomised trial of two different anti-emetic regimens (A and B) was performed in 26 patients with breast carcinoma undergoing emetic i.v. cytotoxic chemotherapy. They all received oral Motival (nortriptylene/fluphenazine) for 48 h after therapy and for regimen A received N-saline i.v. with their cytotoxics whilst for regimen B patients were given 16 mg dexamethasone i.v. Patients were given the alternative regimen at the subsequent course of treatment. They were asked to assess overall nausea and number of vomiting episodes in the 24 h following therapy. There was a statistically significant reduction in both for the regimen containing dexamethasone. This agent causes few side effects and is particularly suited for out-patient use.

References

Jul 1, 1983·Archives of Internal Medicine·P A CassilethS L Gerson
Jun 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M GagenJ Neidhart
Jan 23, 1981·JAMA : the Journal of the American Medical Association·S Frytak, C G Moertel

❮ Previous
Next ❯

Citations

May 3, 1986·Lancet·S G Allan, R C Leonard
Dec 7, 1991·BMJ : British Medical Journal·J F SmythU Bruntsch
Feb 21, 2019·The Cochrane Database of Systematic Reviews·Alison HaywoodJanet R Hardy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here